HCA reports higher second-quarter earnings, lowers 2026 guidance, declares dividend

HCA Healthcare reported second-quarter 2026 revenue of $20.230 billion, up 8.7%, and diluted EPS of $7.62, up 11.6%, while same-facility admissions rose 2.5%; the company said uninsured volume reduced pre-tax income by approximately $400 million. HCA lowered its 2026 guidance to $77.0-$79.5 billion in revenue, $6.3-$6.7 billion in net income and $28.70-$30.50 in diluted EPS, while increasing its estimated Medicaid supplemental-payment benefit to $300-$500 million. The board declared a quarterly dividend of $0.78 per share, payable September 30, 2026, to shareholders of record on September 16, 2026.